Semantic Coherence: TECARTUS (Kite Pharma / Gilead Sciences) – Signal Evidence & AI Readability

[H1]
Welcome to the

TECARTUS® patient & caregiver website

TECARTUS® patient and caregiver website

[IMG: Patients and caregivers together.]

[H2] Starting Points
TECARTUS is a CAR T-cell therapy. Explore information that may be helpful to you at different stages of treatment:

Who TECARTUS is for and how it works
chevron_right

Important considerations for TECARTUS
chevron_right

How TECARTUS worked for other patients
chevron_right

Side effects and how they are managed
chevron_right

Information about insurance coverage
chevron_right

TECARTUS treatment steps and preparation guide
chevron_right

TECARTUS infusion and close daily monitoring
chevron_right

Continued monitoring near the treatment center
chevron_right

Getting help to find information along the way
chevron_right

Support and resources for caregivers
chevron_right

Managing side effects at home
chevron_right

Support and resources along the way
chevron_right

Support and resources for caregivers
chevron_right

Have questions? Call us

Your treatment team is the best resource for support throughout treatment.
If you have questions at any step of the CAR T process, our dedicated team at Kite can also help.
You can call them at:

1-844-454-KITE [5483]5483

Monday–Friday
8 am–9 pm ET
5 am–6 pm PT

[H4] You are now leaving TECARTUS.com
The website you are navigating to is not operated or controlled by Kite. Kite is not responsible for the information contained in the linked website.

[H4] You are now leaving TECARTUS.com
You are going to a website that contains clinical information and was created specifically for healthcare professionals.
If you are not a healthcare professional and would like to remain on the patient site, please select cancel.

If you have questions at any step of the CAR T process, our dedicated team at Kite can help.

Get in touch

Approved Uses

TECARTUS is a treatment for adults with mantle cell lymphoma or acute lymphoblastic leukemia ...

Important Safety Information

What is the most important information I should know about TECARTUS?
TECARTUS may cause side effects that are life-threatening and can lead to death ...

Approved Uses and Important Safety Information

Read

Approved Uses
TECARTUS® is a treatment for adults with mantle cell lymphoma or acute lymphoblastic leukemia. It is used following disease progression while on or after other treatment. TECARTUS is different than other cancer medicines because it is made from your own white blood cells, which have been modified to recognize and attack your lymphoma cells.

Important Safety Information

What is the most important information I should know about TECARTUS?

TECARTUS may cause side effects that are life-threatening and can lead to death. Call or see your healthcare provider or get emergency help right away if you get any of the following:

Fever (100.4°F/38°C or higher)
Difficulty breathing
Chills or shaking chills
Confusion
Dizziness or lightheadedness
Severe nausea, vomiting, or diarrhea
Fast or irregular heartbeat
Severe fatigue or weakness

It is important to tell your healthcare provider that you received TECARTUS and to show them your TECARTUS Patient Wallet Card. Your healthcare provider may give you other medicines to treat your side
effects.

Before getting TECARTUS, tell your healthcare provider about all your medical problems, including if you have or have had:
Neurologic problems (such as seizures, stroke, or memory loss)
Lung or breathing problems
Heart problems
Liver problems
Kidney problems
A recent or active infection
Tell your healthcare provider about all the medications you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

How will I receive TECARTUS?
Since TECARTUS is made from your own white blood cells, your blood will be collected by a process called “leukapheresis” (loo-kah-fur-ee-sis), which will concentrate your white blood cells.
Your blood cells will be sent to a manufacturing center to make your TECARTUS.
Before you get TECARTUS, you will get 3 days of chemotherapy to prepare your body.
When your TECARTUS is ready, your healthcare provider will give it to you through a catheter placed into your vein (intravenous infusion). The infusion usually takes less than 30 minutes.
You will be monitored daily for at least 7 days after the infusion.
You should plan to stay close to a healthcare facility for at least 2 weeks after getting TECARTUS. Your healthcare provider will help you with any side effects that may occur.
You may be hospitalized for side effects. Your healthcare provider will discharge you if your side effects are under control and it is safe for you to leave the hospital.
Your healthcare provider will want to do blood tests to follow your progress. It is important that you do have your blood tested. If you miss an appointment, call your healthcare provider as soon as possible to reschedule.

What should I avoid after receiving TECARTUS?
Avoid driving for at least 2 weeks after you get TECARTUS.
Do not donate blood, organs, tissues, or cells for transplantation.

What are the possible or reasonably likely side effects of TECARTUS?
The most common side effects of TECARTUS include:
Fever (100.4°F/38°C or higher)
Low white blood cells (can occur with a fever)
Low red blood cells
Low blood pressure (dizziness or lightheadedness, headache, feeling tired, short of breath)
Fast heartbeat
Confusion
Difficulty speaking or slurred speech
Nausea
Diarrhea
TECARTUS may increase your risk of getting cancers including certain types of blood cancers. Your healthcare provider should monitor you for this.
These are not all the possible side effects of TECARTUS. Call your healthcare provider about any side effects that concern you. You are encouraged to report negative side effects of prescription drugs
to the FDA. Visit www.fda.gov/medwatch or call
1-800-FDA-1088.

Please see Important Facts, including IMPORTANT
WARNINGS.

You’ve reached the end of the Approved Uses and Important Safety Information. Click “Okay” to minimize the tray. You can reopen the full information at any time by clicking the “Read” button at the bottom
of the screen.

[H1]
Managing side effects

[IMG: Medical staff monitoring patient’s possible side effects of CAR T-cell therapy.]

On this page
What are the possible side effects of TECARTUS?
How will the treatment team manage side effects and keep me safe?
What is my role in managing side effects?
During TECARTUS infusion and close monitoring
During continued monitoring
During recovery at home

[H2] What are the possible side effects of TECARTUS?

Because TECARTUS is a treatment that works on your immune system, there is a risk that your immune system may become overactive and affect the rest of your body in unwanted ways. You can learn about the
possible side effects of TECARTUS by reading the Important Safety Information.

Two side effects that many patients have experienced are
Cytokine Release Syndrome (CRS)?
and
Neurotoxicity?:

CRS and Neurotoxicity can become life-threatening and can lead to death. Call or see your healthcare provider or get emergency help right away if you get any of the following:

Fever (100.4°F/38°C or higher)
Difficulty breathing
Chills or shaking chills
Confusion
Dizziness or lightheadedness
Severe nausea, vomiting, or diarrhea
Fast or irregular heartbeat
Severe fatigue or weakness

It is important to tell your healthcare provider that you received TECARTUS and to show them your
TECARTUS Patient Wallet Card. Your healthcare provider may give you other medicines to treat your side effects.

The most common side effects of TECARTUS include:
Fever (100.4°F/38°C or higher)
Low white blood cells (can occur with a fever)
Low red blood cells
Low blood pressure (dizziness or lightheadedness, headache, feeling tired, short of breath)
Fast heartbeat
Confusion
Difficulty speaking or slurred speech
Nausea
Diarrhea
TECARTUS may increase your risk of getting cancers including certain types of blood cancers. Your healthcare provider should monitor you for this.
These are not all the possible side effects of TECARTUS. It’s important to talk to your treatment team about how you are feeling, and let them know if you notice any symptoms. Each
person's experience and potential side effects will be different.

[H2] How will the treatment team manage side effects and keep me safe?
Your safety and care are top priority. There will be multiple safety measures in place throughout your TECARTUS treatment experience:

[H2] What is my role in managing side effects?

Both patients and caregivers play an important role during CAR T treatment. See below for what you can do and how your responsibilities may shift throughout treatment.
Remember that you can always ask your treatment team if you have questions about side effects and how to look for them.

[H2] During TECARTUS infusion and close daily monitoring

To help prepare for your CAR T-cell infusion, your treatment team may give you premedications.
You will be monitored daily for at least 1 week after infusion in case serious side effects happen. During this time, you will be under the care of your treatment team. Serious side effects are most likely in the first few weeks after infusion.

Your treatment team is well equipped to manage and treat side effects. They will regularly complete health checks? and ask you to do some simple tasks? to identify and track any symptoms. If needed, they may treat CRS or neurotoxicity with corticosteroids or other medications.

[IMG: A patient with the oncologist and caregiver during TECARTUS® (brexucabtagene autoleucel) infusion at a certified treatment center.]

Your treatment team is well equipped to manage and treat side effects. They will regularly complete health checks? and ask you to do some simple tasks? to identify and track any symptoms. If needed, they may treat CRS or neurotoxicity with corticosteroids or other medications.

[H4] What you can do
Proactively tell the treatment team if you notice any changes in how you're feeling. Caregivers may be the first to notice side effects, as some symptoms can be difficult for patients to recognize by
themselves.
The treatment team can also answer any questions you may have about side effects and how to look for them.

Learn more about what to expect and how to prepare for this step on the Receiving TECARTUS page.

[H2] During continued monitoring

You should plan to stay close to a healthcare facility for at least 2 weeks after infusion, so you can get help quickly if any side effects occur. Your treatment team will let you know where this continued monitoring will take place.

[IMG: A caregiver closely monitoring a patient while the patient recovers at home.]

[H4] What you can do
Follow your treatment team's instructions for monitoring for signs and symptoms of side effects. You will be responsible for monitoring side effects once you've left the center.
Notify your treatment team immediately if you notice any changes. Receiving medical attention right away may keep side effects from becoming more serious.
It is important to tell any healthcare providers you visit that you received TECARTUS, and have your treatment team’s contact information on hand.

“I'm glad we asked lots of questions about what to do and who to call if something happens. We had someone we could call 24/7 during the first 30 days as we transitioned from the treatment center to a temporary apartment close by.”
DavidTECARTUS Patient
This testimonial is representative of the patient’s own experience. Individual treatment results and experience may vary.

[IMG: David TECARTUS® (brexucabtagene autoleucel) patient ambassador sitting in a chair.]

This testimonial is representative of the patient’s own experience. Individual treatment results and experience may vary.

Learn more about what to expect and how to prepare for this step on the Receiving TECARTUS page.

[H2] During recovery at home

When the treatment team thinks you are ready—at least 2 weeks after infusion—you'll no longer be required to stay near a healthcare facility. If you had to travel for treatment, this means you can now return home. You may also start returning to your local oncologist for follow-up appointments.

[IMG: A patient recovering at home after treatment with continued caregiver support.]

[H4] What you can do
Continue to look out for side effects and talk to your healthcare teams about how you are feeling. Make sure to attend follow-up appointments. If you miss an appointment, it's important to reschedule as soon as possible.
You should continue to tell any healthcare providers you visit that you received TECARTUS.

Learn more about what to expect and how to prepare for this step on the Receiving TECARTUS page.

Have questions? Call us

Your treatment team is the best resource for support throughout treatment.
If you have questions at any step of the CAR T process, our dedicated team at Kite can also help.
You can call them at:

1-844-454-KITE [5483]5483

Monday–Friday
8 am–9 pm ET
5 am–6 pm PT

Back to Top
expand_less

[H4] You are now leaving TECARTUS.com
The website you are navigating to is not operated or controlled by Kite. Kite is not responsible for the information contained in the linked website.

[H4] You are now leaving TECARTUS.com
You are going to a website that contains clinical information and was created specifically for healthcare professionals.
If you are not a healthcare professional and would like to remain on the patient site, please select cancel.

[H3]
Cytokine Release Syndrome (CRS)

SY-toh-kine reh-LEES SIN-drome

CRS happens when your immune system becomes overactive.
After infusion, when the modified T cells recognize and kill cancer cells, they may release proteins called cytokines.

A buildup of cytokines can lead to symptoms including:
fever
chills
rapid heart rate
low blood pressure
low blood oxygen level
CRS typically lasts between 1–2 weeks and typically begins in the first week after infusion, when you are staying at the treatment center under the care of the treatment team.

[H3] Neurotoxicity
NOOR-oh-tok-SIH-sih-tee

Neurotoxicity is a side effect that happens when there is damage to the brain and spinal cord.
Neurotoxicity can cause symptoms like:
changes in the way the brain functions
seizures
changes in level of consciousness
difficulty with speech
tremors
confusion

Symptoms of neurotoxicity can last for 2–3 weeks and typically begin around 1 week after TECARTUS infusion.

Certified treatment centers

In order to provide TECARTUS, cancer treatment centers must first be certified. Certified treatment centers have specifically-trained medical staff, strict treatment protocols, and safety measures in place
for CAR T-cell therapy. These centers are often first to use best care practices learned through research.
Certified treatment centers are sometimes known as authorized treatment centers, or certified healthcare facilities.

Approved Uses

TECARTUS is a treatment for adults with mantle cell lymphoma or acute lymphoblastic leukemia ...

Important Safety Information

What is the most important information I should know about TECARTUS?
TECARTUS may cause side effects that are life-threatening and can lead to death ...

Approved Uses and Important Safety Information

Read

Approved Uses
TECARTUS® is a treatment for adults with mantle cell lymphoma or acute lymphoblastic leukemia. It is used following disease progression while on or after other treatment. TECARTUS is different than other cancer medicines because it is made from your own white blood cells, which have been modified to recognize and attack your lymphoma cells.

Important Safety Information

What is the most important information I should know about TECARTUS?

TECARTUS may cause side effects that are life-threatening and can lead to death. Call or see your healthcare provider or get emergency help right away if you get any of the following:

Fever (100.4°F/38°C or higher)
Difficulty breathing
Chills or shaking chills
Confusion
Dizziness or lightheadedness
Severe nausea, vomiting, or diarrhea
Fast or irregular heartbeat
Severe fatigue or weakness

It is important to tell your healthcare provider that you received TECARTUS and to show them your TECARTUS Patient Wallet Card. Your healthcare provider may give you other medicines to treat your side
effects.

Before getting TECARTUS, tell your healthcare provider about all your medical problems, including if you have or have had:
Neurologic problems (such as seizures, stroke, or memory loss)
Lung or breathing problems
Heart problems
Liver problems
Kidney problems
A recent or active infection
Tell your healthcare provider about all the medications you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

How will I receive TECARTUS?
Since TECARTUS is made from your own white blood cells, your blood will be collected by a process called “leukapheresis” (loo-kah-fur-ee-sis), which will concentrate your white blood cells.
Your blood cells will be sent to a manufacturing center to make your TECARTUS.
Before you get TECARTUS, you will get 3 days of chemotherapy to prepare your body.
When your TECARTUS is ready, your healthcare provider will give it to you through a catheter placed into your vein (intravenous infusion). The infusion usually takes less than 30 minutes.
You will be monitored daily for at least 7 days after the infusion.
You should plan to stay close to a healthcare facility for at least 2 weeks after getting TECARTUS. Your healthcare provider will help you with any side effects that may occur.
You may be hospitalized for side effects. Your healthcare provider will discharge you if your side effects are under control and it is safe for you to leave the hospital.
Your healthcare provider will want to do blood tests to follow your progress. It is important that you do have your blood tested. If you miss an appointment, call your healthcare provider as soon as possible to reschedule.

What should I avoid after receiving TECARTUS?
Avoid driving for at least 2 weeks after you get TECARTUS.
Do not donate blood, organs, tissues, or cells for transplantation.

What are the possible or reasonably likely side effects of TECARTUS?
The most common side effects of TECARTUS include:
Fever (100.4°F/38°C or higher)
Low white blood cells (can occur with a fever)
Low red blood cells
Low blood pressure (dizziness or lightheadedness, headache, feeling tired, short of breath)
Fast heartbeat
Confusion
Difficulty speaking or slurred speech
Nausea
Diarrhea
TECARTUS may increase your risk of getting cancers including certain types of blood cancers. Your healthcare provider should monitor you for this.
These are not all the possible side effects of TECARTUS. Call your healthcare provider about any side effects that concern you. You are encouraged to report negative side effects of prescription drugs
to the FDA. Visit www.fda.gov/medwatch or call
1-800-FDA-1088.

Please see Important Facts, including IMPORTANT
WARNINGS.

You’ve reached the end of the Approved Uses and Important Safety Information. Click “Okay” to minimize the tray. You can reopen the full information at any time by clicking the “Read” button at the bottom
of the screen.

[H1]
Support and resources

[IMG: Patient support treatment team.]

On this page
Is TECARTUS covered by insurance?
Who can help me find information on resources and support?
Where else can I find support?
TECARTUS video library
Share your story
Downloadable resources

[H2] Is TECARTUS covered by insurance?
Many insurance plans provide coverage for treatment.
You can talk to your healthcare team to discuss all the costs associated with TECARTUS, including out-of-pocket costs?.

How do I find out if my insurance covers TECARTUS?
chevron_right

If you don't have insurance, talk to your healthcare team about options available to you. There are other organizations that may be able to provide support if you are prescribed TECARTUS.

[H2] Who can help me find information on resources and support?

You don't have to figure everything out by yourself. Your treatment team is the best resource for support throughout treatment.
Our knowledgeable team at Kite is also dedicated to helping answer your questions about the treatment process.
You can call them at:

1-844-454-KITE [5483]

Monday–Friday
8 am–9 pm ET or 5 am–6 pm PT

[IMG: Individual talking to the Kite Team on the phone.]

[H2] Where else can I find support?

Many organizations offer help throughout the process. The lists below are a starting point for finding organizations that may offer assistance programs. This is not an exhaustive list of support programs. You can ask your treatment team about other support that might be available.

Resources may include referrals to independent third-party nonprofit patient assistance programs. These programs are not operated or controlled by Kite, and Kite does not endorse any program or third-party organization. Nonprofit patient assistance program eligibility requirements may vary and are established solely by each independent organization. Kite makes no guarantee with respect to reimbursement or copay assistance for any item or service.

Financial support
chevron_right

Travel and lodging support
chevron_right

Day-to-day support
chevron_right

Mental health, emotional support, and peer groups
chevron_right

Physical wellness support
chevron_right

Educational support
chevron_right

“When you need help, it’s important to just ask for it. Even when it felt hard for me, and my brain was going several different places, my wife was a rock star. It's a team effort.”

DavidTECARTUS Patient

This testimonial is representative of the patient’s own experience. Individual treatment results and experience may vary.

[IMG: David TECARTUS® (brexucabtagene autoleucel) patient ambassador with caregiver wife Patti.]

This testimonial is representative of the patient’s own experience. Individual treatment results and experience may vary.

There are also additional resources available just for caregivers. You can find links on the Caregiver support page.

[H2] TECARTUS video library
Patient and caregiver stories:
This testimonial is representative of the patient's and caregiver’s own experience. Individual treatment results and experience may vary.

[IMG: Patient and caregiver treatment story video thumbnail.]

David and Patti
Listen to a patient and caregiver talk about their treatment experience with TECARTUS
Play Video
play_arrow

Learn about TECARTUS, and the TECARTUS treatment process. These animations may help you explain TECARTUS and the TECARTUS treatment process to family and friends.

[IMG: Video thumbnail displaying T cells and how CAR T works.]

What is CAR T-cell therapy?
Play Video
play_arrow

[IMG: TECARTUS® (brexucabtagene autoleucel) treatment process video thumbnail.]

What is the treatment process?
Play Video
play_arrow

[H2] Share your story

Treatment stories may help educate and inspire others. If you have completed treatment and want to share your story with us, learn more at
mykitecartstory.com.

mykitecartstory.com
chevron_right

[H2] Downloadable resources

TECARTUS Patient
Wallet Card
chevron_right

TECARTUS Treatment Overview Book: English
chevron_right

TECARTUS Treatment Overview Book: Español
chevron_right

Have questions? Call us

Your treatment team is the best resource for support throughout treatment.
If you have questions at any step of the CAR T process, our dedicated team at Kite can also help.
You can call them at:

1-844-454-KITE [5483]5483

Monday–Friday
8 am–9 pm ET
5 am–6 pm PT

Back to Top
expand_less

[H4] You are now leaving TECARTUS.com
The website you are navigating to is not operated or controlled by Kite. Kite is not responsible for the information contained in the linked website.

[H4] You are now leaving TECARTUS.com
You are going to a website that contains clinical information and was created specifically for healthcare professionals.
If you are not a healthcare professional and would like to remain on the patient site, please select cancel.

[H3] Out-of-pocket costs

There are out-of-pocket costs involved in the CAR T treatment process. ‘Out-of-pocket’ is any cost a patient has that is not covered by a health insurance plan. Examples include deductibles, co-payments for covered services, and costs for services that are not covered.

[H3] How do I find out if my insurance covers TECARTUS?

[IMG: Individual calling insurance provider for coverage information.]
If you're considering TECARTUS, your treatment team will look into your insurance coverage as part of the CAR T consultation process. They will work with your insurance provider to determine
what your coverage will be. They can also answer any questions you may have.
You may need to provide the following information in order to review your insurance coverage:
Your oncologist's name and phone number
The name of your treatment center and location
Your insurance member ID #
Other information that can be found on your insurance card

[H3] Financial support

[H4] American Cancer Society

Patient Programs and Services

for help during and after cancer treatment

[H4]
Bone Marrow & Cancer Foundation

Financial Assistance Programs

financial assistance for patients and their families

[H4] BMT InfoNet

Patient Assistance Fund

helps with living expenses during treatment

[H4] CancerCare

Financial & Co-Payment Assistance

helps with treatment-related costs and finding additional resources

[H4] Cancer Support Community

Helpline

financial navigation, and treatment lodging and transportation resources, and other services

[H4] Family Reach Foundation

Get Help

financial assistance, tips, and resource navigation

[H4] Leukemia & Lymphoma Society

Financial Support

a list of financial assistance programs

[H4] Lymphoma Research Foundation

Helpline

phone or email service for financial assistance resources and other information

Patient Aid Grant

limited financial assistance to patients who are underinsured or struggle to pay for medical expenses

[H4] National Cancer Institute

Managing Costs and Medical Information

[H4] Patient Advocate Foundation

Patient Advocate Foundation

a selection of services that address financial and other obstacles to accessing healthcare

The organizations listed above are independent from Kite and Gilead, and this list is subject to change. This information is provided as a resource for patients and is not an endorsement or guarantee of
assistance.

[H3] Travel and lodging support

[H4]
Air Care Alliance

Patient and Medical Transport

organizes flights to help patients access distant medical care

[H4] American Cancer Society

Hope Lodge

home-like lodging environments for patients undergoing treatment

Patient Programs and Services

programs providing financial assistance, travel, lodging support, and more

Road to Recovery

transportation to and from treatment

[H4] BMT InfoNet

Patient Assistance Fund

helps with living expenses during treatment

[H4] Cancer Support Community

Helpline

treatment lodging and transportation resources, financial navigation, and other services

[H4] Corporate Angel Network

Corporate Angel Network

arranges free air travel for cancer patients on corporate planes

[H4] Footprints in the Sky

Footprints in the Sky

arranges free air travel for patients on charter and corporate planes

[H4] Grace On Wings

Grace On Wings

provides charity air ambulance services

[H4] Healthcare Hospitality Network

Need medical lodging?

a tool to search for a place to stay near your treatment center

[H4] Joe’s House

Joe’s House

helps patients find affordable places to stay when traveling for medical treatment

[H4] Leukemia & Lymphoma Society

Financial Support

a list of financial assistance programs, including lodging, transportation, and other non-medical expenses

[H4] Mercy Medical Angels

Mercy Medical Angels

assists with the cost of ground and air travel for patients needing to access medical care

[H3] Day-to-day support

[H4]
American Cancer Society

Patient Programs and Services

Road to Recovery program provides rides to patients to get to their cancer treatment

[H4] CancerCare

Resource Navigation

navigators and oncology social workers help connect patients and caregivers to resources

Pet Assistance and Wellness
Program

assists with keeping a cat or dog at home while going through cancer treatment

[H4] Cancer Support Community

Helpline

treatment lodging and transportation resources, financial navigation, and other services

[H4] Leukemia & Lymphoma Society

Meals at Your Door

meal delivery service

One-On-One Nutrition Consultations

with registered dieticians

[H3] Mental health, emotional support, and peer groups

[H4] BMT InfoNet

Coping with Stress During CAR T-cell Therapy

Caring Connections Program

talk to a patient or caregiver who has been through CAR T treatment

[H4] Cancer.net

Counseling

information about counseling and finding a counselor

Resources for LGBTQ+ People

Support Groups

information about support groups and how to find one

[H4] CancerCare

Support Groups

led by professional oncology social workers

Counseling

Young Adults

information, resources, and support for young adults affected by cancer

Older Adults

information, resources, and support to help older people cope with cancer

[H4]
Cancer Support Community

MyLifeLine

online community of patients, survivors, and caregivers

[H4] Leukemia & Lymphoma Society

Support Groups

search for support groups for anyone affected by blood cancer

Patti Robinson Kaufmann First Connection® Program

peer-to-peer support

[H4] Leukemia Research Foundation

Peer Support

online support community and one-on-one mentoring program

[H4] Lymphoma Research Foundation

Lymphoma Support Network

a one-to-one peer support program

[H4] Patient Empowerment Network

Non-Hodgkin’s Lymphoma Friends

a peer support community for patients living with Non-Hodgkin’s Lymphoma, and their caregivers

[H3] Physical wellness support
[H4]
American Cancer Society
Coping and Living Well During Cancer Treatment
[H4] American Institute for Cancer Research
Tips throughout treatment
[H4]
CancerCare

Information about nutrition

Information about sleep

[H4]
Cancer Support Community

Exercise for wellness guide

Diet and nutrition tips

[H4] Leukemia & Lymphoma Society
Food and nutrition information
including one-on-one nutrition consultations
[H4]
Lymphoma Research Foundation
Exercise and nutrition information

Approved Uses

TECARTUS is a treatment for adults with mantle cell lymphoma or acute lymphoblastic leukemia ...

Important Safety Information

What is the most important information I should know about TECARTUS?
TECARTUS may cause side effects that are life-threatening and can lead to death ...

Approved Uses and Important Safety Information

Read

Approved Uses
TECARTUS® is a treatment for adults with mantle cell lymphoma or acute lymphoblastic leukemia. It is used following disease progression while on or after other treatment. TECARTUS is different than other cancer medicines because it is made from your own white blood cells, which have been modified to recognize and attack your lymphoma cells.

Important Safety Information

What is the most important information I should know about TECARTUS?

TECARTUS may cause side effects that are life-threatening and can lead to death. Call or see your healthcare provider or get emergency help right away if you get any of the following:

Fever (100.4°F/38°C or higher)
Difficulty breathing
Chills or shaking chills
Confusion
Dizziness or lightheadedness
Severe nausea, vomiting, or diarrhea
Fast or irregular heartbeat
Severe fatigue or weakness

It is important to tell your healthcare provider that you received TECARTUS and to show them your TECARTUS Patient Wallet Card. Your healthcare provider may give you other medicines to treat your side
effects.

Before g

[H1]
TECARTUS
at a glance

[IMG: Two individuals and a medical professional looking at a tablet.]

On this page
Who is TECARTUS for?
How does TECARTUS work?
What's important to know when considering TECARTUS?

[H2] Who is TECARTUS for?
TECARTUS is used to treat two different types of blood cancers in adults:

Mantle Cell Lymphoma (MCL) in adult patients, when:
another treatment did not work, or
the cancer returned after treatment

B-cell Acute Lymphoblastic Leukemia (ALL) in adult patients, when:
another treatment did not work, or
the cancer returned after treatment

Over 4,000 patients have been treated with TECARTUS.*
Ask your doctor if TECARTUS is an option for you.
*As of July 2025, this number includes global internal Kite commercial and clinical trial data.

[H2] How does TECARTUS work?

TECARTUS is a type of CAR T-cell therapy?. CAR T is different from other cancer treatments because it is made from your own T cells.

[IMG: Video thumbnail displaying T cells and how CAR T works.]

What is CAR T-cell therapy?
Play Video
play_arrow

Flip through the story below to understand how TECARTUS helps your T cells recognize and attack certain blood cancers.

[IMG: T cells and cancer cells in the body.]

T cells are part of your immune system, and help your body fight diseases, from the common cold to cancer.
Hide Allunfold_less

[IMG: Cancer cells hiding from T cells in the human body.]

But in some blood cancers, your T cells cannot recognize the cancer cells, which can allow the cancer cells to grow.

[IMG: T cells collected from patient.]

To make your CAR T cells, your own T cells are collected from your blood and sent to the manufacturing facility.

[IMG: T cells modified to have chimeric antigen receptors (CARs).]

There, your T cells are modified to have
Chimeric Antigen Receptors (CARs)?. This turns them into CAR T cells. This is a careful process that usually takes around 2 weeks and has many quality checks.

[IMG: Patient receiving millions of CAR T cells by infusion.]

On the day of your TECARTUS treatment, you receive millions of CAR T cells by infusion.

[IMG: Cancer cells destroyed by CAR T cells.]

Once in your body, your new CAR T cells can now recognize certain blood cancer cells and attack them.

[IMG: Patient monitored closely by a treatment team member.]

After receiving TECARTUS, you will be monitored daily for at least 1 week for any side effects.
Hide Allunfold_less

chevron_left Prev
View Allunfold_more
Nextchevron_right

[H2] What’s important to know when considering TECARTUS?

Here are three special considerations that may be different from your experience with other cancer treatments. There may be other considerations depending on your situation. Ask your oncologist or treatment
team for more information.

You can expect to be monitored daily for at least 1 week after infusion, and have multiple appointments before and after. Visit the
Receiving TECARTUS page to learn more.
Your treatment team will let you know how close you need to stay to a healthcare facility for the first 2 weeks after infusion. If you don’t live nearby, you may need to travel, find lodging, and consider other costs.
Find and learn about a treatment center close to you:
Use the locator tool
TECARTUS may cause side effects that are life-threatening and can lead to death. Your treatment team at the treatment center will be working with you to closely monitor and manage side effects.
Some side effect symptoms can be hard for patients to recognize, and this is one of the reasons you will need a dedicated caregiver. If you don’t have a dedicated caregiver, you can work with your treatment team to come up with a solution.
Visit the Managing side effects page and Important Facts about TECARTUS to learn more.
Each step of treatment can take time to organize and prepare for.
Talk to your treatment team about planning for CAR T.

“For us the key to the CAR T experience was knowledge about when, where, and why each step will happen. We asked lots of questions to get a better understanding of the process, and wrote things down on paper so we didn't miss
anything.”

DavidTECARTUS Patient

This testimonial is representative of the patient’s own experience. Individual treatment results and experience may vary.

[IMG: David TECARTUS® (brexucabtagene autoleucel) patient ambassador.]

This testimonial is representative of the patient’s own experience. Individual treatment results and experience may vary.

[H3]
CAR T-cell therapy
kar T-sel THAYR-uh-pee
CAR T-cell therapy, or CAR T for short, is a type of immunotherapy. In CAR T, your T cells are modified to recognize and attack certain cancer cells. This is done by modifying your T cells to have Chimeric Antigen Receptors (CARs). This turns them from T cells into CAR T cells.
[IMG: A T cell modified to have CAR which then becomes a CAR T cell.]

[H3] Chimeric Antigen Receptors
ky-MEER-ik AN-tih-jen reh-SEP-ter
A Chimeric Antigen Receptor (CAR) is a special molecule designed to help T cells recognize and attack cancer cells.
CARs hook onto a specific marker that cancer cells have a lot of. These markers are called antigens. When CARs hook onto these antigens, it can cause T cells to respond.
With TECARTUS, the CARs hook onto CD19, which is found on cancerous and normal B cells.
[IMG: A chimeric antigen receptor (CAR) hooking onto CD19.]

[H3] Treatment center locator tool
There are over 160 cancer centers that provide TECARTUS throughout the US. When choosing a location, consider that you will need to stay close to a center for at least 2 weeks after receiving TECARTUS.
You can use the locator tool to find and learn about nearby treatment centers and their teams.
Information on new centers (where available) will be added on an ongoing basis. You can also contact your treatment team to learn more.

Traveling From

Typical driving times around your location

1 hour
2 hours

Copy link
Print information

Treatment centers are independent facilities that dispense Kite CAR T therapies. Choice of a treatment center is within the sole discretion of the physician and patient. Kite does not endorse any individual treatment sites. Insurance coverage should be considered when reviewing treatment center options.

Have questions? Call us

Your treatment team is the best resource for support throughout treatment.
If you have questions at any step of the CAR T process, our dedicated team at Kite can also help.
You can call them at:

1-844-454-KITE [5483]5483

Monday–Friday
8 am–9 pm ET
5 am–6 pm PT

Back to Top
expand_less

[H4] You are now leaving TECARTUS.com
The website you are navigating to is not operated or controlled by Kite. Kite is not responsible for the information contained in the linked website.

[H4] You are now leaving TECARTUS.com
You are going to a website that contains clinical information and was created specifically for healthcare professionals.
If you are not a healthcare professional and would like to remain on the patient site, please select cancel.

If you have questions at any step of the CAR T process, our dedicated team at Kite can help.

Get in touch

Certified treatment centers

In order to provide TECARTUS, cancer treatment centers must first be certified. Certified treatment centers have specifically-trained medical staff, strict treatment protocols, and safety measures in place
for CAR T-cell therapy. These centers are often first to use best care practices learned through research.
Certified treatment centers are sometimes known as authorized treatment centers, or certified healthcare facilities.

Approved Uses

TECARTUS is a treatment for adults with mantle cell lymphoma or acute lymphoblastic leukemia ...

Important Safety Information

What is the most important information I should know about TECARTUS?
TECARTUS may cause side effects that are life-threatening and can lead to death ...

Approved Uses and Important Safety Information

Read

Approved Uses
TECARTUS® is a treatment for adults with mantle cell lymphoma or acute lymphoblastic leukemia. It is used following disease progression while on or after other treatment. TECARTUS is different than other cancer medicines because it is made from your own white blood cells, which have been modified to recognize and attack your lymphoma cells.

Important Safety Information

What is the most important information I should know about TECARTUS?

TECARTUS may cause side effects that are life-threatening and can lead to death. Call or see your healthcare provider or get emergency help right away if you get any of the following:

Fever (100.4°F/38°C or higher)
Difficulty breathing
Chills or shaking chills
Confusion
Dizziness or lightheadedness
Severe nausea, vomiting, or diarrhea
Fast or irregular heartbeat
Severe fatigue or weakness

It is important to tell your healthcare provider that you received TECARTUS and to show them your TECARTUS Patient Wallet Card. Your healthcare provider may give you other medicines to treat your side
effects.

Before getting TECARTUS, tell your healthcare provider about all your medical problems, including if you have or have had:
Neurologic problems (such as seizures, stroke, or memory loss)
Lung or breathing problems
Heart problems
Liver problems
Kidney problems
A recent or active infection
Tell your healthcare provider about all the medications you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

How will I receive TECARTUS?
Since TECARTUS is made from your own white blood cells, your blood will be collected by a process called “leukapheresis” (loo-kah-fur-ee-sis), which will concentrate your white blood cells.
Your blood cells will be sent to a manufacturing center to make your TECARTUS.
Before you get TECARTUS, you will get 3 days of chemotherapy to prepare your body.
When your TECARTUS is ready, your healthcare provider will give it to you through a catheter placed into your vein (intravenous infusion). The infusion usually takes less than 30 minutes.
You will be monitored daily for at least 7 days after the infusion.
You should plan to stay close to a healthcare facility for at least 2 weeks after getting TECARTUS. Your healthcare provider will help you with any side effects that may occur.
You may be hospitalized for side effects. Your healthcare provider will discharge you if your side effects are under control and it is safe for you to leave the hospital.
Your healthcare provider will want to do blood tests to follow your progress. It is important that you do have your blood tested. If you miss an appointment, call your healthcare provider as soon as possible to reschedule.

What should I avoid after receiving TECARTUS?
Avoid driving for at least 2 weeks after you get TECARTUS.
Do not donate blood, organs, tissues, or cells for transplantation.

What are the possible or reasonably likely side effects of TECARTUS?
The most common side effects of TECARTUS include:
Fever (100.4°F/38°C or higher)
Low white blood cells (can occur with a fever)
Low red blood cells
Low blood pressure (dizziness or lightheadedness, headache, feeling tired, short of breath)
Fast heartbeat
Confusion
Difficulty speaking or slurred speech
Nausea
Diarrhea
TECARTUS may increase your risk of getting cancers including certain types of blood cancers. Your healthcare provider should monitor you for this.
These are not all the possible side effects of TECARTUS. Call your healthcare provider about any side effects that concern you. You are encouraged to report negative side effects of prescription drugs
to the FDA. Visit www.fda.gov/medwatch or call
1-800-FDA-1088.

Please see Important Facts, including IMPORTANT
WARNINGS.

You’ve reached the end of the Approved Uses and Important Safety Information. Click “Okay” to minimize the tray. You can reopen the full information at any time by clicking the “Read” button at the bottom
of the screen.